Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Vascular Reactivity Profile of Novel KCa 3.1-Selective Positive-Gating Modulators in the Coronary Vascular Bed.
Journal: Basic & clinical pharmacology & toxicology
Published: August 27, 2015
The riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed KCa2 activator and NaV blocker, is a potent novel anticonvulsant.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: September 27, 2014
New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1.
Journal: Molecular pharmacology
Published: June 25, 2014
The therapeutic potential of small-conductance KCa2 channels in neurodegenerative and psychiatric diseases.
Journal: Expert opinion on therapeutic targets
Published: July 26, 2013
Triarylmethanes, a new class of cx50 inhibitors.
Journal: Frontiers in pharmacology
Published: March 20, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026